Old Web
English
Sign In
Acemap
>
Paper
>
Morbidity Endpoints (ME) in the Amnog Process in Germany: Are me Less Important in Oncology Substances?
Morbidity Endpoints (ME) in the Amnog Process in Germany: Are me Less Important in Oncology Substances?
2016
K. Bakker
T. Volmer
Keywords:
Intensive care medicine
AMNOG
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]
map